Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited (BSE: 500087) (NSE: CIPLA) today announced that it ...
India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes: Nandita Vijayasimha, Bengaluru Wednesday, September 9, 2026, 08:00 Hrs [ ...
Mumbai: Cipla's wholly owned US subsidiary Invagen Pharmaceuticals Inc has entered into a strategic partnership with Qilu ...
Invagen Pharmaceuticals, a wholly owned subsidiary of Cipla announced that it has entered into a strategic partnership with Qilu Pharmaceutical, for the exclusive licensing and supply of QL2107, a ...
Cipla announces partnership with Qilu Pharma to license and supply of biosimilar to Keytruda in US: Our Bureau, Mumbai Friday, September 4, 2026, 12:20 Hrs [IST] Invagen Pharmaceu ...
As geopolitical tensions between the U.S. and China grow increasingly complicated, here are five alternative territories for ...
Zacks Investment Research on MSN
Pfizer stock rises almost 9% in 3 months: Time to buy, hold or exit?
Pfizer PFE stock has risen 8.6% in the past three months as investors have gained confidence in the company’s ability to ...
Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and ...
Amgen and AstraZeneca recently reported positive Phase 3 CROSSING results showing TEZSPIRE improved histologic remission and ...
Newsable Asianet News on MSN
Goyal at Bharat Health Expo 2026: Focus on R&D, not just generics
Union Minister Piyush Goyal inaugurated Bharat Health Global Expo 2026, urging the pharma industry to focus on R&D, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results